http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20160150239-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a74935159a0a871dd85e00c138f7fe6b |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-245 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate | 2015-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1015a1ff2a4fac14e154d792c4c43120 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dc9837ab4bf843edb3500b8b215a692 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f5180533ccd11aef34fdda10f9de333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40d1e90d9d27b08aff3611aa9691ee83 |
| publicationDate | 2016-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20160150239-A |
| titleOfInvention | Lipid biomarkers for diagnosis of acute transplant rejection in liver transplantation |
| abstract | The present invention relates to a lipid body biomarker for the diagnosis of acute liver transplant rejection, and more particularly to a lipid biomarker for the diagnosis of acute liver transplant rejection, which comprises an agent for measuring the level of plasma plasmalogen and / or ceramide. A kit for diagnosing acute liver transplantation rejection reaction comprising the composition, and a method for providing information for diagnosing acute liver transplant rejection. The lipid body biomarker of the present invention is a noninvasive diagnostic marker of rejection of liver transplantation. It can diagnose post-transplant liver damage early, enables customized treatment such as proper administration of immunosuppressant, It is possible to prevent socioeconomic loss caused by |
| priorityDate | 2015-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.